You Position: Home > Paper
FOLFOX方案与FOLFIRI方案治疗晚期大肠癌的疗效比较
( views:220, downloads:13 )
- Author:
- No author available
- Journal Title:
- JOURNAL OF THE FOURTH MILITARY MEDICAL UNIVERSITY
- Issue:
- 17
- DOI:
- 10.3321/j.issn:1000-2790.2007.17.053
- Key Word:
- 大肠肿瘤;化疗;草酸铂;伊立替康
Abstract： @@ 0 引言草酸铂(L-OHP)联合5-FU/CF组成的FOLFOX方案和伊立替康(CPT-11) 联合5-FU/CF组成的FOLFIRI方案近年来在晚期大肠癌的治疗中都取得了较好的疗效. 2002-1/2005-12我们应用FOLFOX方案和FOLFIRI方案治疗晚期大肠癌45例,进行疗效和毒副作用比较.
- [1]管忠震,孙晓非,冯奉仪,等.依立替康（Irinotecan,CPT-11）治疗晚期大肠癌临床研究[J].1999,(6).
- [2]Di Lullo L,Nuzzo A,Rea S,etc.Multicenter phase II study of CPT-11 fractionated over two days with bimonthly leucovorin and 5-fluorouracil in patients with metastatic colorectal cancer.[J].2003,23(3C).
- [3]孙燕,管忠震,金懋林,等.奥沙利铂单药或与氟尿嘧啶-甲酰四氢叶酸联合应用治疗晚期大肠癌Ⅱ期临床试用报告[J].1999,(3).